Downloads: 5
India | Ayurveda | Volume 14 Issue 4, April 2025 | Pages: 2149 - 2155
Clinical Study of Haridradi Ghrita and Saindhavadi Parisheka in the Management of Sushkakshipaka (Computer Vision Syndrome)
Abstract: Computer Vision Syndrome (CVS), also known as Digital Eye Strain (DES) and Visual Fatigue (VF), results from prolonged digital device use. It presents with visual, ocular, and extraocular symptoms like blurred vision, photophobia, dryness, headache, and musculoskeletal strain. CVS shares clinical features with Sushkakshipaka, a Sarvagata Netra Roga caused by Vata dosha, leading to inflammation and dryness due to reduced tears. This study aimed to evaluate the clinical effectiveness of Haridradi Ghrita and Saindhavadi Parisheka in the management of Sushkakshipaka. A total of 50 patients, aged 16 to 50 years, were selected for the clinical study in accordance with diagnostic criteria and were being assessed for 30 days. The trial drug Haridradi Ghrita and Saindhavadi Parisheka had been given in calculated dosage of 15ml BD orally and 600 matras in morning through local application respectively. Efficacy was assessed using subjective parameters and objective parameters. Results showed significant improvements in symptoms like Eye redness (Raga) (64%), Eye pain (Shula) (65%), Burning (61%), Tearing (Bheda) (61%) etc. Very significant relief was seen in Difficulty focusing for near vision (Divitya Patala Timira lakshna) and in case of Dryness (Vishushkatva) having p value being p= 0.003 and in the symptom of Asthenopia p value is p=0.002. Objective parameters like Schirmer?s test (38%) and Tear Film Break-Up Time (30%) showed the improvement in clinical features having p<0.0001. The overall effects suggested that effectiveness of Haridradi Ghrita and Saindhavadi Parisheka was discovered to be an effective formulation in managing Sushkakshipaka (Computer Vision Syndrome) having no adverse effects.
Keywords: Computer Vision Syndrome, Sushkakshipaka, Digital Eye Strain (DES), Haridradi Ghrita, Saindhavadi Parisheka
Rating submitted successfully!
Received Comments
No approved comments available.